• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊克里特岛与德国南部(巴登 - 符腾堡州中部)皮肤恶性黑色素瘤发病率及临床特征的比较分析

Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).

作者信息

Lasithiotakis K, Leiter U, Krüger-Krasagakis S, Tosca A, Garbe C

机构信息

Melanoma Unit, Dermatology Department, Medical School of Heraklion, University of Crete, Greece.

出版信息

Br J Dermatol. 2006 Jun;154(6):1123-7. doi: 10.1111/j.1365-2133.2006.07163.x.

DOI:10.1111/j.1365-2133.2006.07163.x
PMID:16704644
Abstract

BACKGROUND

Comparative analysis of the incidence rates and epidemiological features of cutaneous malignant melanoma (CMM) between different ethnic groups exposed to varying environmental factors is critical for consideration of the causes of CMM but can also be utilized in a public health approach to control of the disease.

OBJECTIVES

To compare incidence rates and clinical features of CMM in a Greek and a central European population (central Baden-Württemberg, Germany).

METHODS

Incident cases of CMM were traced in all hospitals of the island of Crete for the period 1999-2002. Age-standardized incidence rates per 100 000 inhabitants per year for the European Standard Population were calculated based on the Cretan population statistics. A comparison was performed between the Cretan findings and those of southern Germany as registered by the hospital-based Central Malignant Melanoma Registry, which likewise documents more clinical features than normally recorded by population-based cancer registries.

RESULTS

Mean incidence rates in Crete for 1999-2002 were 4.01 per 100 000 inhabitants per year for males and 4.05 for females as compared with 10.6 for males and 11.1 for females in southern Germany. There were striking differences in the clinical characteristics of CMMs, with significantly higher tumour thickness in Crete (median 1.4 mm vs. 0.7 mm in southern Germany). Correspondingly, significantly more nodular melanomas were observed in Crete (29%) as compared with southern Germany (11%).

CONCLUSIONS

Incidence of CMM in Crete, with about four cases per 100 000 inhabitants per year, is clearly higher than previously estimated, and there is an urgent necessity for earlier recognition of CMM in Crete. However, the incidence of CMM in southern Germany is much higher.

摘要

背景

对暴露于不同环境因素的不同种族群体之间皮肤恶性黑色素瘤(CMM)的发病率和流行病学特征进行比较分析,对于探究CMM的病因至关重要,同时也可用于公共卫生层面的疾病防控。

目的

比较希腊和中欧人群(德国巴登-符腾堡州中部)中CMM的发病率及临床特征。

方法

追踪1999年至2002年期间克里特岛所有医院的CMM确诊病例。根据克里特岛人口统计数据,计算出欧洲标准人口每年每10万居民的年龄标准化发病率。将克里特岛的研究结果与德国南部基于医院的中央恶性黑色素瘤登记处的数据进行比较,该登记处记录的临床特征比基于人群的癌症登记处通常记录的更多。

结果

1999年至2002年期间,克里特岛男性的平均发病率为每年每10万居民4.01例,女性为4.05例,而德国南部男性为10.6例,女性为11.1例。CMM的临床特征存在显著差异,克里特岛的肿瘤厚度明显更高(中位数为1.4毫米,而德国南部为0.7毫米)。相应地,与德国南部(11%)相比,克里特岛观察到的结节性黑色素瘤明显更多(29%)。

结论

克里特岛CMM的发病率约为每年每10万居民4例,明显高于先前的估计,因此迫切需要在克里特岛更早地识别CMM。然而,德国南部CMM的发病率要高得多。

相似文献

1
Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).希腊克里特岛与德国南部(巴登 - 符腾堡州中部)皮肤恶性黑色素瘤发病率及临床特征的比较分析
Br J Dermatol. 2006 Jun;154(6):1123-7. doi: 10.1111/j.1365-2133.2006.07163.x.
2
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.头颈部黑色素瘤是一种独特的疾病实体吗?一项基于临床登记的对5702例黑色素瘤患者的比较研究。
Br J Dermatol. 2006 Oct;155(4):771-7. doi: 10.1111/j.1365-2133.2006.07455.x.
3
The incidence of cutaneous melanoma on Crete, Greece.希腊克里特岛皮肤黑色素瘤的发病率。
Int J Dermatol. 2006 Apr;45(4):397-401. doi: 10.1111/j.1365-4632.2006.02492.x.
4
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.德国南部皮肤黑色素瘤的发病率和死亡率:1976年至2003年按解剖部位和病理特征划分的趋势
Cancer. 2006 Sep 15;107(6):1331-9. doi: 10.1002/cncr.22126.
5
Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.1956年至2005年50年间加拿大中部皮肤恶性黑色素瘤的发病率及解剖学表现
J Am Acad Dermatol. 2009 Jul;61(1):44-50. doi: 10.1016/j.jaad.2009.01.020. Epub 2009 Apr 23.
6
Population-based incidence rates of malignant melanoma of the vulva in Germany.德国外阴恶性黑色素瘤的基于人群的发病率
Gynecol Oncol. 2005 Jan;96(1):216-21. doi: 10.1016/j.ygyno.2004.09.052.
7
Cutaneous malignant melanoma--clinical epidemiology and survival.皮肤恶性黑色素瘤——临床流行病学与生存率
J Indian Med Assoc. 1998 Jan;96(1):19-20, 28.
8
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.25年来皮肤黑色素瘤预后因素与生存率的发展:德国皮肤病学会中央恶性黑色素瘤登记处的分析
Cancer. 2005 Feb 1;103(3):616-24. doi: 10.1002/cncr.20816.
9
Epidemiology and clinical and pathologic characteristics of cutaneous malignant melanoma in Abruzzo (Italy).意大利阿布鲁佐地区皮肤恶性黑色素瘤的流行病学、临床及病理特征
Int J Dermatol. 2009 Jul;48(7):718-22. doi: 10.1111/j.1365-4632.2009.03974.x.
10
Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.中欧恶性黑色素瘤的流行病学:风险因素与预后预测指标。德国皮肤病学会中央恶性黑色素瘤登记处的结果。
Pigment Cell Res. 1992;Suppl 2:285-94. doi: 10.1111/j.1600-0749.1990.tb00387.x.

引用本文的文献

1
Assessment of tumoral and peritumoral inflammatory reaction in cutaneous malignant melanomas.评估皮肤恶性黑色素瘤中的肿瘤和肿瘤周围炎症反应。
Rom J Morphol Embryol. 2023 Jan-Mar;64(1):41-48. doi: 10.47162/RJME.64.1.05.
2
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.miRNAs(微小 RNA)在黑色素瘤免疫治疗中的作用。
Int J Mol Sci. 2022 Nov 25;23(23):14775. doi: 10.3390/ijms232314775.
3
Cumulative Sun Exposure and Melanoma in a Population-Based Case-Control Study: Does Sun Sensitivity Matter?一项基于人群的病例对照研究中的累积日照与黑色素瘤:日光敏感性是否重要?
Cancers (Basel). 2022 Feb 16;14(4):1008. doi: 10.3390/cancers14041008.
4
Serum Total 25-Hydroxyvitamin D Levels in Patients With Cutaneous Malignant Melanoma: A Case-Control Study in a Low-Risk Southern European Population.皮肤恶性黑色素瘤患者的血清总25-羟基维生素D水平:一项针对低风险南欧人群的病例对照研究
Dermatol Pract Concept. 2019 Dec 31;10(1):e2020010. doi: 10.5826/dpc.1001a10. eCollection 2020.